Ken Fisher
ALNY icon

Ken Fisher’s Alnylam Pharmaceuticals ALNY Stock Holding History

Ken Fisher’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2M Buy
+6,045
New +$2.06M ﹤0.01% 575

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ken Fisher's ALNY Position: Q1 2026 in Review

Ken Fisher opened a new position in Alnylam Pharmaceuticals (ALNY) in Q1 2026: 6,045 shares worth $2M. The stake represents ﹤0.01% of the portfolio and ranks #575 among its holdings.

787 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Ken Fisher held 6,045 shares of Alnylam Pharmaceuticals worth $2M as of Q1 2026.
  • Alnylam Pharmaceuticals was a new Ken Fisher position in Q1 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #575 holding.
  • 787 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.